PART I Overview Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering R&D advancements ac...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001232524-26-000013 | EDGAR | 121K words |
| 2025-02-26 | 2024-12-31 | 0001232524-25-000011 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001232524-24-000015 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001232524-23-000015 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001232524-22-000012 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0001232524-21-000016 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001232524-20-000016 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001232524-19-000013 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001232524-18-000018 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001232524-17-000024 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001232524-25-000074 | EDGAR | 43K words |
| 2025-08-06 | 2025-06-30 | 0001232524-25-000063 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001232524-25-000027 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001232524-24-000086 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001232524-24-000068 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0001232524-24-000033 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001232524-23-000052 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001232524-23-000037 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001232524-23-000026 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001232524-22-000046 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001232524-22-000035 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001232524-22-000022 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-24 | 0001232524-26-000012 | EDGAR | 10K words |
| 2026-01-12 | 0001193125-26-009899 | EDGAR | — |
| 2025-11-17 | 0001193125-25-283887 | EDGAR | — |
| 2025-11-05 | 0001232524-25-000073 | EDGAR | — |
| 2025-10-28 | 0001628280-25-046763 | EDGAR | — |
| 2025-10-22 | 0001193125-25-245815 | EDGAR | — |
| 2025-08-05 | 0001232524-25-000061 | EDGAR | — |
| 2025-07-25 | 0001232524-25-000051 | EDGAR | — |
| 2025-07-10 | 0001193125-25-157388 | EDGAR | — |
| 2025-05-06 | 0001232524-25-000025 | EDGAR | — |
177 total filings indexed. 145 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001232524 |
| Ticker | JAZZ |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L2 |
| Website | https://www.jazzpharmaceuticals.com |
| Listed | 2007-06-01 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report